Ezekowitz Alan 4
4 · Fulcrum Therapeutics, Inc. · Filed Jun 29, 2022
Insider Transaction Report
Form 4
Ezekowitz Alan
Director
Transactions
- Other
Stock Option (right to buy)
2022-06-28−500→ 14,500 totalExercise: $11.82Exp: 2030-12-02→ Common Stock (500 underlying) - Award
Stock Option (right to buy)
2022-06-27+19,000→ 19,000 totalExercise: $5.22Exp: 2032-06-26→ Common Stock (19,000 underlying)
Footnotes (2)
- [F1]This option was granted on June 27, 2022 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service.
- [F2]No value was received for the cancellation of these stock options, which were originally granted on December 3, 2020.